Nomination Opens for “Directors Of The Year Awards 2022” ACN Newswire

Nomination Opens for “Directors Of The Year Awards 2022”

22 6 月, 2022
HONG KONG, Jun 22, 2022 - (ACN Newswire via SEAPRWire.com) - The "Directors Of The Year Awards 2022" organised by The Hong Kong Institute of Directors ("HKIoD") is open for nomination now. Themed "From Resilience to Sustainability", the Awards this year recognises directors and boards capable of leading their companies in adapting to changes and, with outstanding governance thinking and practical strategies skills, taking their companies towards sustainable development in the ever-changing business environment.Dr Christopher To, Chairman of HKIoD, said, "Leadership in crisis calls for the ability to rethink and redefine some long-standing values or structure, and also the courage and strength to brave the uphill. In the at large uncertain environment now, we must keep learning, evolving, adapting and changing, to make sure the 'new normal' is a 'better normal'. Marking HKIoD's 25th Anniversary, this year's award is themed 'From Resilience to Sustainability', reflective of what we have learnt over the years. Resilience is the most important quality a company needs to survive in the ever-changing world and sustainability is the ultimate goal of every company. I hope all of you can nominate directors and boards standing out in these two aspects, that we may take as examples to inspire all in the business sector to excel."Mr Richard Ho, Chairman of 2022 Directors Awards Organising Committee, said, "When discussing the award theme this year, the Committee thought though the global scene is still unpredictable and challenging, it has become clearer. Thus, we decided to have 'From Resilience to Sustainability' as the theme easier to grasp. We hope to commend those outstanding leaders who braved the challenges from the pandemic and helped their companies achieve good results, and also to remind those in different sectors to set their eyes on long-term strategy and advance towards their sustainable development goal."Dr Carlye Tsui, CEO of HKIoD, said, "All of us, companies or individuals, have gotten used to staying clam in the turbulent environment. With our feet firmly on the ground, it is time that we head again towards our long-term targets. Directors, as leaders of a company, should be sensitive at all times to changes in the market and plan the 'next step' to take. For example, Web3.0 is the latest and a major trend likely to bring revolutionary changes in the near future to all of us. Business leaders who do not have a good understanding of it might just miss the opportunities that come with it. Offering diverse and innovative courses, HKIoD helps members refresh what has been learnt and acquire new knowledge, so that they may be ready any time to take their companies forward."Nomination for the Awards will close on 1 August 2022. On the Judging Panel are business leaders, professionals and regulatory body representatives in Hong Kong. The Directors Of The Year Awards 2022 recognise excellence in the following categories:Company Categories / Director Categories1. Listed Companies / 1. Executive Directors2. Non-Listed Companies / 2. Non-Executive Directors3. Statutory/Non-Profit-Distributing Organisations* / 3. BoardsNotes: *A non-profit-distributing organisation is defined as an organisation which profits are not distributed to its shareholders, members, directors, employees or any other persons, and with objectives including, but not limited to, charitable welfare, social service, health and medical care, education, research, trade and industrial alliance, professional advancement, self-help support, etc.The selection criteria for winners in the Individual Director Categories include: successful pursuit of strategic corporate business/non-profit functions, contribution to board effectiveness in strategic planning and monitoring of performance, implementing compliance, risk control and accountability measures, managing change and succession, and leadership and other attributes and qualities, including keen at continuing professional development, business ethics and other achievements. As for the Collective Board Categories, the judging criteria include: board composition, effectiveness in pursuing strategic corporate/non-profit functions, development and execution of strategic plans and monitoring of performance, implementing compliance, risk control and accountability measures, managing change and succession, development of the board, effectiveness of board committees, business ethics and other achievements.The Awards nomination form and related information are available on The Hong Kong Institute of Directors website www.hkiod.com.About Directors Of The Year AwardsLaunched in 2001, the Directors Of The Year Awards was the first of its kind organised in Asia. It is now an annual project of impact in the community. Its objectives are to recognise directors and board of directors for outstanding director practices and corporate governance, to publicise the significance of good corporate governance and to promote awareness of good corporate governance and director professionalism in Hong Kong. Nominations are open to the public. As good corporate governance is vital to all types of organisations, and professional practices from directors in all board roles are encouraged, the Awards recognise excellence in categories by company types, including listed companies, private companies and statutory/non-profit-distributing organisations, and categories by roles, including Executive Directors, Non-Executive Directors and Boards. For more details on the previous years' Awards, please visit http://www.hkiod.com/dya-awardees.html.About The Hong Kong Institute of DirectorsThe Hong Kong Institute of Directors is Hong Kong's premier body representing directors to foster the long-term success of companies through advocacy and standards-setting in corporate governance and professional development for directors. A non-profit-distributing organisation with membership consisting of directors from listed and non-listed companies, HKIoD is committed to providing directors with educational programmes and information service and establishing an influential voice in representing directors. With international perspectives and a multi-cultural environment, HKIoD conducts business in biliteracy and trilingualism. Website: http://www.hkiod.com.Media Enquiries:Strategic Public Relations GroupBrenda Chan +852 2114 4396 brenda.chan@sprg.com.hkChak Yau +852 2114 4395 chak.yau@sprg.com.hkFax: +852 2114 4948Directors Of The Year Awards 2022 Enquiries:The Hong Kong Institute of DirectorsOdessa So +852 2889 4988 odessa.so@hkiod.com Joanne Yam +852 2889 1414 joanne.yam@hkiod.comFax: +852 2889 9982 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
G20 committed to financing better pandemic response ACN Newswire

G20 committed to financing better pandemic response

22 6 月, 2022
JAKARTA, Jun 22, 2022 - (ACN Newswire via SEAPRWire.com) - The G20 members and several relevant international organizations agreed to work together to create the Financial Intermediary Fund (FIF) to help countries in need to face any pandemic in the future.Indonesian Health Minister Budi Gunadi Sadikin (L) and Indonesian Finance Minister Sri Mulyani (R) at the first G20 Joint Finance and Health Ministerial Meeting held in Yogyakarta, 21 June. (ANTARA/AstridFaidlatulHabibah)During the 1st G20 Joint Finance and Health Ministerial Meeting held in Yogyakarta on Tuesday, Indonesian Finance Minister Sri Mulyani emphasized the urgency for collaborative work between health and finance sectors to better prepared for future pandemics, considering that the COVID-19 would not be the last."The world is definitely watching us - how the G20 is going to respond with delivering concrete action in pandemic preparedness and response. The world is waiting for us," Mulyani remarked.Furthermore, she also asserted the importance of inclusivity in the work of FIF, led together by the World Health Organization (WHO) and the World Bank, which required the involvement of both developed and developing countries."Only then, we can be effective in preparing to tackle the next global pandemic together," Mulyani stated."I would like to acknowledge the central role of the WHO in fighting pandemic and the importance of including the voice of developing countries in our institutional arrangement to create the most effective system for pandemic preparedness and response," she added.The WHO and the World Bank estimated that US$31 billion is required annually for strengthening global health security, according to WHO Director General Tedros Adhanom Ghebreyesus.About two-third of that fund could come from existing resources but that leaves a gap of US$10 billion per year. Hence, he expects that the FIF would help close that gap.WHO and the World Bank have been cooperating to establish the FIF, which would be overseen by a board that takes a decision on funding allocation supported by a technical advisory panel.Both the board and the technical advisory panel would be supported by the joint WHO-WB secretariat based at the Bank's headquarters in Washington, with assisting staff from the WHO.According to the plan, the Bank will provide financial and administrative leadership at the secretariat, operate as a representative for the FIF, hold and transfer relief funds, as well as provide administrative services.Meanwhile, the WHO will provide technical leadership; coordinate input for the technical advisory panel; and prepare relevant technical documentation, recommendations, and reports for the council.Both the World Bank and WHO will act as implementing entities, along with other global health partners with relevant expertise, including the Global Fund, the Global Alliance for Vaccines and Immunization (GAVI), and the Coalition for Epidemic Preparedness Innovations (CEPI)."We look forward to your active participation in building and financing a FIF that is inclusive, equitable, and effective in making our world safer from pandemics," Tedros noted.To date, the G20 has pushed for an emergency fundraising commitment of around US$1.1 billion from five member countries and one international social organization to mobilize the role of FIF.The pledges came from the United States, the European Union, Germany, Indonesia, Singapore, and the Wellcome Trust.Additionally, Indonesian Health Minister Budi Gunadi Sadikin stated the meeting was not only focusing on the FIF as the source of funds to face future pandemics, but the world must also think about the uses of funds."Because money is (only) half the solution for the health crisis. We need to translate this money into access to vaccines, medicines, and diagnostic tools," he said at a press conference after the joint ministerial meeting.In order to create such access, he explained, the engagement with private sectors as the producers of vaccines, therapeutics, and diagnostics was crucial."We need to talk to them, to engage with them. How can they maintain a certain volume commitment? How then we will be able to distribute equally and very quickly if the next pandemic happens?" he noted.The establishment of FIF is still in the ongoing discussion that will be continued at the next G20 meetings, hosted this year by Indonesia.However, as the G20 President, Indonesia will continue to gather as much as possible support from more countries as well as an international organization even philanthropists, in order for them to be able to contribute to the financing side of pandemic preparedness and response.Written by: Yashinta Difa Pramudyani, Editor: Fardah Assegaf (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Hexagon and Fujitsu Announce Strategic Partnership to Solve Societal Challenges for ‘Trusted Society’ JCN Newswire

Hexagon and Fujitsu Announce Strategic Partnership to Solve Societal Challenges for ‘Trusted Society’

22 6 月, 2022
HUNTSVILLE, Ala. and Tokyo, Jun 22, 2022 - (JCN Newswire via SEAPRWire.com) - Hexagon's Safety, Infrastructure & Geospatial division and Fujitsu Limited will partner to accelerate the development and promotion of use cases to solve societal challenges and contribute to the realization of the 'Trusted Society' -- a sustainable, resilient place where people can live together in peace and prosperity. The partnership was announced today at HxGN LIVE Global 2022, Hexagon's digital technology conference.Hexagon and Fujitsu will work together to provide joint use cases leveraging digital twin technologies and solutions from both companies, including IoT sensors, data processing, AI analysis and advanced data visualization in the cloud and high-performance computing infrastructure. The partners will deploy these technologies to develop joint solutions that deliver richer information and deeper insights to customers in government, the public sector, transportation and utilities to help reduce emissions, increase safety, optimize operations and more."Our goal at Fujitsu is to realize our vision for a 'Trusted Society'," comments Yoshinami Takahashi, EVP and vice head of Global Solution Business Group, Fujitsu. "Partnering with Hexagon will allow us to extend our reach and provide even greater value to cities and regions around the world.""Cities are playing a leading role in solving global challenges, from addressing climate change to eliminating traffic fatalities," says Steven Cost, president, Hexagon's Safety, Infrastructure & Geospatial division. "Our partnership with Fujitsu can help cities put data to work to solve these pressing problems and meet sustainability and safety goals."The new global partnership builds from the companies' work to solve urban sustainability challenges in Europe, including efforts to better manage and understand the impacts of shared mobility services in Germany, including a project with the City of Munich.Hexagon is a global leader in digital reality solutions, combining sensor, software and autonomous technologies. We are putting data to work to boost efficiency, productivity, quality and safety across industrial, manufacturing, infrastructure, public sector and mobility applications. Our technologies are shaping production and people-related ecosystems to become increasingly connected and autonomous -- ensuring a scalable, sustainable future.Hexagon's Safety, Infrastructure & Geospatial division improves the resilience and sustainability of the world's critical services and infrastructure. Our solutions turn complex data about people, places and assets into meaningful information and capabilities for better, faster decision-making in public safety, utilities, defense, transportation and government.Hexagon (Nasdaq Stockholm: HEXA B) has approximately 22,000 employees in 50 countries and net sales of approximately 4.3bn EUR. Learn more at hexagon.com and follow us @HexagonAB.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Hexagon Emily Arnold Global Communications Manager Tel: +1 256.730.2582 E-mail:Emily.arnold@hexagon.comFujitsu Limited Public and Investor Relations Division Inquiries (bit.ly/3rrQ4mB) Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
CT Event Asia to host The 2nd Annual Clean Power & New Energy 2022 ACN Newswire

CT Event Asia to host The 2nd Annual Clean Power & New Energy 2022

21 6 月, 2022
KUALA LUMPUR, June 21, 2022 - (ACN Newswire via SEAPRWire.com) - This year, CT Event Asia is all set to bring you the 2nd Annual Clean Power & New Energy 2022, themed "Shaping the Future of Energy in Asia". Happening at the Mandarin Oriental Hotel on 20th-21st July 2022, this conference is the most efficient and targeted event for utility scale renewable companies. Bringing these industries together will create more value for participants by enhancing opportunities to network, broadening the scope of education and providing access to an exclusive audience.Incorporating all renewable technologies will be more convenient and cost-effective for multi-tech businesses as well as companies specializing in wind, utility solar, artificial intelligence in the Energy sector, Green hydrogen energy, Bioenergy, Internet of energy and Engineering in renewable who will benefit from an efficient business development forum that attracts decision makers from large-scale developers, corporate buyers and utilities.Attracting 500+ senior representatives from across the leading utility leaders, Government bodies, Renewable Energy companies, Engineering Procurement, Construction and Management, Economists, Financiers, Power Generation and Investors to discover how the Economic, Financial and Political framework for Energy is evolving, and to assess the implications of growing renewable deployment for the future shape of the Energy Industry. Here is our speaker list!Join us now to get more insights from industry leaders on the future of Energy in Asia and meet our Sponsors and Partners as well with all of this to explore, our 2nd Annual Clean Power and New Energy 2022 is set out to be bigger than ever! Here's our list of Sponsors and Partners.The 2nd Annual Clean Power & New Energy 2022 website has full details about the program. Interested parties can visit the website here or request for the event brochure here.To get in touch with our team for enquires relating to this event, feel free to reach out to:CamaraPartnership DirectorCT Event Asia+60 16 283 2660 | +03 2710 7756camara@cteventasia.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

抗疫助稳 兴业银行为外贸企业纾困解难

21 6 月, 2022
HONG KONG, Jun 21, 2022 - (亚太商讯 via SEAPRWire.com) - 近日，记者从兴业银行了解到，该行认真落实党中央、国务院关于外贸保稳提质的工作部署，加大跨境融资信贷投放力度，加强跨境人民币业务支持，大力发展外贸新业态金融服务，全力支持外贸企业复工复产和全球展业。今年1-5月，兴业银行跨境人民币收支5123亿元，同比增长158%；跨境融资余额1813亿元，较年初增长24%。“多亏了兴业在线跨境人民币结算绿色通道，原先办理一笔跨境收款的资金解付至少需要半天至一天时间，现在半个小时内搞定，有效缓解了我们经营资金周转难题。”北京一家电子行业头部企业财务负责人感慨道。目前兴业银行北京分行已为该企业办理跨境人民币结算逾100亿元，跨境人民币在线绿色通道，正为国内众多外贸类企业的进出口业务保驾护航。数据显示，1-5月，兴业银行实现本外币跨境结算量1253亿美元，同比增长19%。疫情之下，兴业银行持续完善跨境在线融资体系，近期该行将推出“跨境E贷”在线融资产品，基于数据模型，可实现线上为小微出口企业核定信贷额度和放款，将大幅提升小微企业的融资效率，为出口企业提供便捷、高效、低成本融资服务，助力企业拓展海外市场。外贸新业态新模式是推动我国外贸转型升级和高质量发展的新动能，兴业银行持续推进外贸新业态项下跨境业务发展，服务好跨境电商、海外仓、市场采购贸易、外贸综合服务、新型离岸贸易等领域，打通外贸新业态资金流转链路，为外贸企业保稳提质注入金融活水。以跨境电商为例，兴业银行搭建跨境电商综合服务平台，服务跨境电商进出口企业200多户，前5个月带动跨境结算量7.31亿美元。“兴业银行将加快推进跨境电商综合服务平台升级，加强与跨境电商平台、支付公司等外部平台和机构的合作，构建跨境贸易生态圈，为贸易新业态企业提供全方位金融支持。”兴业银行国际业务部负责人表示。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
MOKWHEEL Unveils Basalt, An Epic Power Backup Ebike with the Most Innovative Features SeaPRwire

MOKWHEEL Unveils Basalt, An Epic Power Backup Ebike with the Most Innovative Features

21 6 月, 2022
New York City, NY, June 21, 2022 (SEAPRWire) – This month, Mokwheel has announced its highly anticipated Basalt Ebike line. The new electric bicycle line will be available in a step-over and step-through model, which are compatible with power inverters and batteries for the electric bike to use. The Basalt Ebike, in its entirety, holds power and features integrated power station technology that the market has never seen before. With a series of patented power station concept manufacturers in mind, Mokwheel is ready to take off this revolutionary technology and start making history in the e-mobility industry. The Basalt line plans to work toward greener solutions for clean transportation efficiently. “Our goal is to be the leading force of revolutionizing intelligent transportation products to make the world more sustainable and efficient,” the company revealed. Key features of Mokwheel Basalt Ebike include: 1. Portable power station that can be utilized to charge up devices and appliances on the go. 2. A massive battery capacity allows an extended range of up to 85-miles on a single charge. 3. Flexible and adaptive hydraulic front fork for smoothing bumps and improving off-road capability. 4. The ability to customize different riding styles with pedal-assist and throttle mode. 5. Two 26*4-inch fat tires improve traction and grip with shock absorption capacity. 6. IPX5-rated water resistance allows users to ride in most weather conditions. The Ebike also hosts technology that lets you experience the freedom of the open road without limiting your movement or compromising your safety. Tektro Auriga E-Comp hydraulic brakes, with adjustable suspension and two 26-inch fat tires, provide tremendous grip and mechanical stability to allow you to ride with confidence in a variety of unpredictable terrain. “Not only are we developing innovative electric bikes that are already on the market, but we want to overcome the barrier of making Ebikes smarter and bringing something new to the public that they have never seen before. We want to provide value to our customers and society,” said Denny, CEO of Mokwheel. The Mokwheel Basalt Ebike campaign kicks off in Jun. 26th on Indiegogo, a crowdfunding platform. Follow the Mokwheel Basalt campaign and turn on the notification to receive an early bird discount. Mokwheel is a start-up specializing in creating intelligent, practical, and innovative electric vehicles that change the face of the electric transportation field. Based on the company’s proprietary power station technology, Mokwheel creates ground-breaking electric bicycle products to revolutionize the transportation industry. The company focuses on quality and prioritizes products that can provide meaningful experiences. The Mokwheel team is led by Denny L, a young entrepreneur, dedicated to outshining the existing electric bicycle market by providing user-friendly products that meet the demands of today’s consumers. Media Contact Brand Name: Mokwheel Email: support@mokwheel.com Web: https://www.mokwheel.com/ SOURCE: Mokwheel The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More
Mazda 787B to Drive Demo Laps in Le Mans Classic 2022 JCN Newswire

Mazda 787B to Drive Demo Laps in Le Mans Classic 2022

21 6 月, 2022
HIROSHIMA, Japan, Jun 21, 2022 - (JCN Newswire via SEAPRWire.com) - Mazda Motor Corporation announced that the Mazda 787B, symbol of Mazda's "never stop challenging" spirit, will do demonstration laps(1) at Le Mans Classic 2022 to be held from June 30 to July 3.1991 Le Mans winner, Mazda 787B, at Le Mans drivers' parade on June 10, 2011Equipped with a four-rotor rotary engine, the Mazda 787B became the first Japanese automobile to win the 24 Hours of Le Mans endurance race in 1991. For the first time in almost a decade, spectators will be able to witness the thrilling and distinctive sound of the Mazda 787B's rotary engine at Le Mans Classic 2022. The last two opportunities to see the legendary vehicle being at the 90th anniversary of the 24 hours of Le Mans in 2013 and the 20th anniversary of Mazda's victory at Le Mans in 2011.The Mazda 787B was due to run at Le Mans Classic last year to mark the 30th anniversary of its victory, unfortunately the event itself was postponed to this year due to Covid-19.Thanks to support from model car company, Spark, 29-time competitor in the 24 Hours of Le Mans, Yojiro Terada dubbed as "Mr. Le Mans" in Japan, will drive the Mazda 787B during demonstration laps on July 1 and 2 when Group C racing will be held.Le Mans Classic is a very popular event in which numerous famed racing cars that have previously competed in the 24 Hours of Le Mans(2) gather and make an appearance every two years on the Circuit de la Sarthe. In Group C, entry vehicles are divided by historical period and compete in 60-minute races. This year's entries will include cars that have cemented their names in history such as the Toyota Tom's 85C, the Porche 962, the Jaguar XJR and the Peugeot 905.For Mazda 787B, visit the special website commemorating the 30th anniversary of Mazda's victory at Le Mans, www.mazda.com/en/innovation/lemans30th/. (1) In case of rain or other poor weather conditions, the demonstration laps by Mazda 787B may be cancelled.(2) 2022 24 Hours of Le Mans marked 99 years since the event first ran in 1923. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
The Mechanism of Action of SinoMab’s Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S. ACN Newswire

The Mechanism of Action of SinoMab’s Flagship Product SM03 is Successfully Published in the Journal of Immunology, a Reputable Journal on Immunology in the U.S.

21 6 月, 2022
HONG KONG, Jun 21, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong listed biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative therapeutics for the treatment of immunological diseases, primarily mAb-based biologics, today announced that, on 10 June 2022, the mechanism of action of its flagship product SM03 (Suciraslimab) is successfully published in the Journal of Immunology, a reputable journal on immunology in the US (link to the paper: https://www.jimmunol.org/content/early/2022/06/10/jimmunol.2100820 ).Figure: Mechanism of Action of SM03 (Suciraslimab)The Journal of Immunology (the JI), founded in 1916 and managed and published by the American Association of Immunologists, is the world's leading peer-reviewed journal in the field of immunology, with a 5-year impact factor of 6.029 (Journal Citation Reports 2020), and publishes the latest immune-related findings in basic and clinical research in the field of immunology. It also publishes the latest research papers in the field of immunology, including cellular immunology, immunochemistry and molecular immunology, immunogenetics and immunomodulation, immunopathology and clinical immunology, immunopharmacology, microbial immunology, oncology and transplantation.The Company's flagship product SM03 (Suciraslimab) is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis (RA). The patient enrollment for the Phase III clinical trial in China has been completed by the end of 2021, with a total of 530 subjects recruited. The trial is a multi-centre clinical study led by Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences, with clinical centres in 44 hospitals including Gulou Hospital of Nanjing University School of Medicine, the Second Hospital of Harbin Medical University and the First Hospital of Shanxi Medical University. The Company expects to lock the database at the end of June this year, read out the results of the Phase III clinical trial data in early August and will have biologics license application (BLA) in 2023. In addition, the development of Suciraslimab has also received support from the 863 Program, the "12th Five-Year Plan" and the "13th Five-Year Plan" for development of major new drugs, as well as the green channel for "prioritized review and approval" by the Center for Drug Evaluation (CDE). Previously, a phase II clinical trial led by Peking Union Medical College Hospital has demonstrated the efficacy and safety of Suciraslimab for the treatment of RA.The Company's flagship product Suciraslimab is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis. The core competitive advantage of this product over the standard therapies currently on the market is its novel and unique mechanism of action, which ensures that Suciraslimab is comparable to other products in terms of efficacy, while having significant advantage in terms of safety, which is a major concern for patients on long-term medication for autoimmune diseases.Under normal operation of human's immune system, B-cell receptor (BCR) pathway would be activated and create strong signals in response to foreign ("non-self") antigens and trigger a series of B-cell immune responses. To differentiate from our "self" antigens, our body would recruit molecules, like SHP-1, to inhibit or reduce BCR-induced signaling, thereby suppressing B-cell immune responses. We suggested that the recruitment of these molecules such as SHP-1 could be achieved by conversion of cis-binding CD22 to trans-binding CD22, thus suppressing relevant immune responses. Due to ageing or genetic predisposition, patients with autoimmune diseases such as RA are unable to convert cis-binding CD22 to trans-binding CD22, and are thus unable to recruit immunosuppressive molecules such as SHP-1 to inhibit or reduce the transmission of antigenic stimuli from B-cell receptors to B-cells, which then generate a series of immune responses, such as the secretion of large amounts of antibodies to attack autoantigens. Our flagship product, Suciraslimab, can facilitate the conversion of cis-binding CD22 to trans-binding CD22, forming a stable CD22 trans-binding structure, thereby restoring the tolerance of B-cells to autoantigens and inhibiting a series of relevant immune responses by B cells to attack the body.Historical data shows that Suciraslimab has a significant safety advantage compared to other products with comparable efficacy currently available in the market. Existing RA therapies include traditional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) such as methotrexate (MTX), biologic DMARDs (bDMARDs) targeting tumour necrosis factor (TNF), interleukin (IL)-6 receptors and other targets, as well as targeted synthetic DMARDs (tsDMARDs) such as Janus kinase (JAK) inhibitors and other small molecule drugs, all of which have played an important role in the remission of RA patients. However, most of the mechanisms of action of existing RA therapies will result in the depletion or death of B cells, which can have a series of side effects on human's autoimmune system, thus posing a long-term risk for patients with autoimmune diseases who require long-term medication, as the weakening of the immune system will naturally lead to the development of other debilitating diseases. In contrast, the mechanism of action of Suciraslimab is very different from that of existing therapies on the market. We only inhibit the B-cell related immune response by altering the binding of CD22 and recruiting related inhibitory molecules. Suciraslimab only inhibits the autoimmune response by regulating the function of B-cells and does not damage the B-cells and does not affect the normal function of B-cells in the immune system. Therefore, Suciraslimab has a significant safety advantage over other products currently available on the market.The autoimmune disease drug market has been touted as the next gold mine after oncology drugs. As the "king of drugs" in the world, Humira has topped the global drug ranking for eight years with sales of US$19.832 billion in 2020, making other drugs "bow down". Globally, pharmaceutical giants are focusing on the research and development of drugs in the rheumatic immune field, with the most prominent ones including Pfizer, Novartis, Johnson & Johnson and AbbVie, all with more than a dozen products in development or marketed in their respective pipelines. The global autoimmune disease drugs market is valued at US$113.7 billion in 2018 and is expected to reach US$152.3 billion by 2023 at a CAGR of 6.0%. The market for autoimmune disease drugs in China is expected to grow from RMB13.4 billion in 2018 to RMB37.7 billion in 2030 at a CAGR of 23%. Driven by the global trend of innovation, R&D in rheumatic immune field in China is also gaining momentum. As a leading pharmaceutical innovator in China, Hengrui Pharma has also adopted a strategy of early development, target optimization and expansion of indications in the rheumatic immune field, aiming to fully capitalize on the rapid development of the autoimmune disease market in China. This indicates that SinoMab's mission and vision to become a global leader in innovative therapies for immune and other debilitating diseases are in line with the development trend of the entire pharmaceutical industry. In the foreseeable future, it is believed that SinoMab will help more and more patients suffering from autoimmune diseases and become a leading global biopharmaceutical company focusing on innovative therapies for autoimmune diseases.In addition to its flagship product Suciraslimab, the Company's core product SN1011 has an expanding scope of indications and continues to receive regulatory approval for new drug applications in China and abroad, and also expects to rapidly initiate Phase II clinical trials for pemphigus vulgaris (PV), multiple sclerosis (MS), systemic lupus erythematosus (SLE) and neuromyelitis optica spectrum disorder (NMOSD) this year. SinoMab also dosed first healthy subject in Phase I clinical trial of its major product SM17 in the U.S. in June 2022. By targeting upstream mediators of the Th2 inflammatory cascade, SM17 is able to control inflammatory airway diseases such as asthma caused by the immune cascade at a relatively early stage and is expected to benefit a large number of patients with severe uncontrolled asthma by satisfying unmet medical needs.About SinoMab BioScience LimitedSinoMab BioScience Limited (stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis (RA) and is currently in Phase III clinical trial for RA in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), pemphigus vulgaris (PV), non-Hodgkin's lymphoma (NHL), asthma, and other diseases with major unmet clinical needs. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
中国抗体的旗舰产品舒西利单抗SM03的作用机理在美国免疫领域权威期刊the Journal of Immunology上成功发表 ACN Newswire

中国抗体的旗舰产品舒西利单抗SM03的作用机理在美国免疫领域权威期刊the Journal of Immunology上成功发表

21 6 月, 2022
HONG KONG, Jun 21, 2022 - (亚太商讯 via SEAPRWire.com) - 中国抗体制药有限公司（“中国抗体”或“公司”，连同其附属公司，统称“集团”；股份代号：3681.HK），一家专注于研究、开发、制造及商业化免疫疾病创新疗法的香港生物制药上市公司，主要研制以单克隆抗体为基础的生物药，欣然宣布，其旗舰产品SM03舒西利单抗（Suciralimab）的作用机理已于2022年6月10日在美国免疫领域权威期刊the Journal of Immunology上成功发表（论文链接：https://www.jimmunol.org/content/early/2022/06/10/jimmunol.2100820 ）。图：舒西利单抗SM03（Suciraslimab）作用机理The Journal of Immunology（the JI），于1916年创刊，由美国免疫学家协会管理和出版，是世界上免疫学领域的顶级同行评鉴刊物，5年影响因子为6.029（2020年期刊引文报告），发布免疫学领域在基础研究和临床研究上的和免疫相关的最新发现，同时发表免疫学领域的最新研究论文，包括细胞免疫学、免疫化学和分子免疫学、免疫遗传学和免疫调节、免疫病理学和临床免疫学、免疫药理学、微生物免疫学、肿瘤和移植。公司旗舰产品舒西利单抗SM03（Suciraslimab）为全球首项用以治疗类风湿性关节炎的潜在抗CD22单抗。该产品已于2021年底在中国完成III期临床试验受试者入组，合计招募530例受试者。该试验为由中国医学科学院北京协和医院牵头的多中心临床研究，临床中心包括南京大学医学院附属鼓楼医院、哈尔滨医科大学附属第二医院、山西医科大学第一医院等44家医院。公司预计今年6月底进行锁库，8月初读出III期临床试验数据结果，并将于2023年申请新药上市（BLA）。此外，舒西利单抗（Suciraslimab）的研发也获得了863计划、“十二五”及“十三五”重大新药创制专项支持，且享受国家药品评审中心（CDE）“优先审评审批”绿色通道。此前，由北京协和医院领导的II期临床试验已验证舒西利单抗（Suciraslimab)对类风湿关节炎治疗有较好的疗效性及较高的安全性。公司旗舰产品舒西利单抗（Suciraslimab）是全球首项用于治疗类风湿性关节炎的潜在抗CD22单抗。该产品与目前市场上现有标准疗法的核心竞争优势在于其新颖独特的作用机理，保证了舒西利单抗在与其他产品疗效相当的情况下，在安全性方面有显着的优势，而安全性正是长期用药的自身免疫疾病患者需要关注的核心问题。在人体免疫系统正常运行的前提下，当外来抗原入侵时，B细胞受体通路会被激活，向B细胞传递抗原刺激信号，引发一系列B细胞免疫反应。而在面对自身抗原时，正常的机体会招募免疫抑制分子如SHP-1，通过阻止或是减弱B细胞受体通路向B细胞传递抗原刺激信号来抑制B细胞相关免疫反应。我们认为，通过转变CD22的结合方式，即CD22从顺式结合转变为反式结合可以达到招募这类免疫抑制分子，如SHP-1，进而达到抑制相关免疫反应的作用。由于年龄或是遗传倾向等原因，RA等自身免疫疾病患者在面对自身抗原时，RA患者的CD22不能从顺式结合方式转变为反式结合，进而不能够招募例如SHP-1的免疫抑制分子来抑制或是减弱B细胞受体向B细胞内传递抗原刺激信号，B细胞接受到抗原刺激信号后，就会产生一系列免疫反应，如分泌大量抗体来攻击自身抗原。而我们的旗舰产品舒西利单抗（Suciraslimab）可以帮助CD22由顺式结合方式转变为反式结合，形成稳定的CD22反式结合结构，进而恢复B细胞对自身抗原的容忍度，抑制B细胞发生一系列相关免疫反应攻击自身机体。通过历史数据与目前市场现有其他产品相比，舒西利单抗（Suciraslimab）在疗效相当的情况下，在安全性方面，相对其他产品有显着的优势。现有RA疗法从甲氨蝶呤（MTX）等传统合成改善病情抗风湿药（csDMARDs），到靶向肿瘤坏死因子（TNF）、白介素（IL）-6受体等靶点的生物制剂DMARDs（bDMARDs），以及靶向合成DMARDs（tsDMARDs），例如Janus激酶（JAK）抑制剂等小分子药物，这些新型药物的引入，对RA患者的病情缓解都起到了重要的作用。但是目前现有RA疗法的大部分作用机理都会导致B细胞的耗竭或是衰亡，对人体自身免疫系统都会产生一系列的副作用，这对需要长期用药的自免疾病患者来说存有长期隐患，免疫系统的衰弱自然而然的会引发其他衰竭性疾病的发生。但是舒西利单抗的作用机理却与目前市场的现有疗法截然不同，我们只是通过改变CD22的结合方式，招募相关抑制分子，进而抑制B细胞相关免疫反应，舒西利单抗只是通过调节B细胞的功能来抑制自身免疫反应，并未损伤到B细胞，不影响B细胞在免疫系统中发挥正常作用。因此，舒西利单抗在相对于目前市场上已有的其他产品，在安全性方面有显着的优势。自身免疫疾病用药市场被誉为继肿瘤之后的下一个金矿。修美乐作为全球“药王”，雄踞全球药物榜首长达8年，2020年198.32亿美元的销售额令其他药品“俯首称臣”。放眼全球，制药巨头十分关注风湿免疫领域药物的研发，最突出的包括辉瑞、诺华、强生和艾伯维，管线中均有十余个在研或上市的产品。全球自身免疫疾病药物市场2018年的市场规模为1,137亿美元，且预计到2023年将达到1,523亿美元，复合年增长率为6.0%，中国自身免疫疾病药物的市场规模预计将从2018年的134亿元人民币增长到2030年的377亿元人民币，复合年增长率为23%。受全球创新浪潮的冲击，我国风湿免疫领域的研发热情同样高涨，恒瑞医药作为国内创新药龙头，在风湿免疫领域也采取了早布局、优靶点和广适应症等策略，希望能够充分享受国内自身免疫疾病市场快速发展的红利。可见中国抗体致力成为免疫性疾病及其他衰竭性疾病创新疗法的全球领导者的使命与愿景是迎合整个医药行业的发展趋势的，在可以预见的未来，相信中国抗体可以造福越来越多受自身免疫疾病困扰的患者，成为全球领先的以自身免疫疾病创新疗法为主的生物制药公司。除旗舰产品舒西利单抗外，公司核心产品SN1011的适应症范围不断扩大，新药研究申请不断获得海内外监管机构的批准，也预计在今年快速启动天疱疮（PV）、多发性硬化症（MS）、系统性红斑狼疮（SLE）、视神经脊髓炎（NMOSD）的二期临床试验，主要产品SM17也在今年6月份在美国刚刚完成临床I期试验首例健康受试者给药，通过靶向Th2细胞相关炎性上游细胞因子通路的疗法，能够在较前端控制免疫级联反应引发的哮喘等炎性气道疾病，希望能够为广大未被满足治疗需求的严重不受控制的哮喘疾病患者带来福音。关于中国抗体制药有限公司中国抗体制药有限公司专注于研究、开发、制造及商业化免疫性疾病疗法。公司注重创新研发，其旗舰产品SM03为全球首项用以治疗类风湿关节炎的潜在抗CD22单抗，已在中国进入类风湿关节炎三期临床试验，并被列为国家十三五重大新药创制专项重大项目。此外还有多个同类靶点首创（First-in-target）及同类首创（First-in-class）在研药物，部分已处于临床阶段，适应症范围覆盖类风湿性关节炎、系统性红斑狼疮、寻常型天疱疮、非霍奇金氏淋巴瘤、哮喘等具有重大未满足临床需求的疾病。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
医思健康订立可持续发展表现挂钩双重贷款 开创香港医疗健康市场先河 ACN Newswire

医思健康订立可持续发展表现挂钩双重贷款 开创香港医疗健康市场先河

21 6 月, 2022
HONG KONG, Jun 21, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团首次订立可持续发展表现挂钩贷款（「可持续发展贷款」），总值为7亿港元。香港上海汇丰银行有限公司（「汇丰银行」）为是次交易的独家放贷方及可持续发展结构银行。集团是次签署可持续发展表现挂钩双重贷款开创了香港医疗健康服务市场先河，不仅强化了集团行业领导地位，亦证明了可持续发展在集团未来发展策略中的重要地位。是次订立之可持续发展贷款由循环信贷和定期贷款组成，贷款所得额将用作一般企业运营资金。集团致力于将联合国 2030可持续发展目标与业务实践相结合，并针对环境、社会和企业管治 (「ESG」) 各要素制定了一系列明确目标，其中包括减少能源消耗、提高员工对ESG工作的参与度以及对标国际标准提升公司治理水平。香港通用检测认证有限公司为领先的可持续发展顾问服务公司，担任本次订立可持续发展贷款的ESG顾问。医思健康执行董事兼首席策略总监及首席投资总监王家琦女士表示︰「首次订立可持续发展贷款是集团发展的重要里程碑，是集团在可持续发展道路迈出的一大步。作为香港领先的医疗健康服务供应商，是次订立贷款体现了集团将可持续发展纳入其核心业务策略的雄心，以及将最佳优化方案逐步融入集团旗下多元品牌日常营运。我们很高兴能将集团的融资策略与关键ESG绩效指标相结合，体现集团对可持续发展的长期承诺，并为香港医疗健康市场后续的可持续金融交易提供借鉴经验。」关于医思健康 香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心，透过多元服务整合发展医疗人工智慧，配套高端品牌及优质客户服务，致力为客户提供最专业、安全、有效的医疗健康服务。集团为恒生综合指数成份股及MSCI香港小型股指数。 集团目前直营的诊所／服务中心主要位于大湾区，提供一站式医疗及健康服务。服务涵盖面极广，旗下主要知名服务品牌包括连续多年荣膺全港第一的一站式医学美容解决方案DR REBORN、专业健发中心发森及多元化多维度的医学服务包括：健康管理中心香港仁和体检中心、疫苗中心香港安苗医疗中心、普通科门诊未来医生、全港最大一站式痛症管理平台纽约脊骨物理治疗中心、全方位牙科服务中心庇利积臣牙科医务所，EC DENTAL CARE及恒健牙科医务所、高端影像中心博思医学诊断中心、仁生肿瘤及癌症中心、内视镜及日间医疗中心仁辉专科中心、专科中心进汇医务中心，联汇专科，新医疗中心、儿科专科汇儿儿科医务中心、妇产科专科卓越医务中心及产前诊断中心、柏立医学化验所、眼科中心唯视眼科和医思兽医医院及影像中心。*根据弗若斯特沙利文公司按2020年及2021年收入计算进行的独立研究若有进一步垂询，请联络：iPR奥美公关刘丽恩 / 陆咏诗 / 叶子欣电话：(852) 2136 6952 / 2169 0467 / 3920 7649传真：(852) 3170 6606电邮：ech@iprogilvy.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More
Fujitsu and Salesforce Japan start collaboration on healthcare solutions for the Japan market JCN Newswire

Fujitsu and Salesforce Japan start collaboration on healthcare solutions for the Japan market

21 6 月, 2022
TOKYO, Jun 21, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu and Salesforce Japan Co., Ltd. (hereinafter Salesforce Japan) today announced the start of a collaboration to create new digital solutions for the healthcare sector in the Japan market. The two companies will promote this initiative by leveraging Fujitsu's expertise in the trusted handling of medical and pharmaceutical data and computing technologies and Salesforce Japan's track record and expertise as an industry leader in customer relationship management (CRM). As the first step of their collaboration, Fujitsu and Salesforce Japan will work together to develop digital solutions for insurance companies in Japan. The two companies will cooperate with insurance companies and medical institutions to support the development of insurance products that optimize the risk assessment of diseases by individuals based on data such as the possibility of diseases predicted by AI from medical and health data. The two parties aim for commercialization of the new solutions in Japan in fiscal 2023.Through the new solutions, Fujitsu and Salesforce Japan will support the establishment of new product models for insurance companies and promote the broad use of personalized insurance products. The two companies thereby aim to contribute to the resolution of societal and economic issues including health concerns related to a variety of diseases associated with the extending life expectancy of individuals, the increase in treatment costs due to advanced medical care, and the cost of living in the retirement period.BackgroundAs society confronts the challenges presented by declining birth rates, aging populations, new threats to public health, and changing lifestyles, insurance companies are working to provide personalized insurance products that are more closely tailored to each applicant?s unique needs. To contribute to this effort, Fujitsu and Salesforce Japan, who started comprehensive cooperation on a global level in 2010, decided to further strengthen their relationship and expand their business through collaborative efforts to create solutions in the healthcare field. Through the development of AI solutions that can predict individual disease risks, the two companies aim to support the development of optimized insurance products based on medical and health data provided by insurers and healthcare providers and to optimize business processes across the entire insurance business.In this way, Fujitsu and Salesforce Japan will support insurance companies in offering prospective policyholders optimal insurance products and creating a new insurance model based on personal data that also covers prevention, diagnosis, treatment, and prognosis in a detailed and comprehensive manner.Roles and responsibilities within the collaborationFujitsu:- Development of a system in cooperation with medical institutions that enables the trusted use of medical data from electronic medical records based on the consent of patients- Development of personalized healthcare services based on Fujitsu's own analysis to detect signs of a specific disease by utilizing "Fujitsu Computing as a Service (CaaS)," a service portfolio that makes it easy for users to take advantage of advanced computing and software technologies such as AISalesforce Japan:- Comprehensive integration and analysis of a wide range of patient medical data to visualize the patient journey(1)- Application of products to realize personalized medical experiences and patient-centered digital transformation (DX) (including ?Health Cloud,? a healthcare industry-specific CRM system that serves as the axis of patient-centric DX; ?MuleSoft,? to integrate external data and ?Tableau,? to analyze patient data)Future plansFujitsu and Salesforce Japan will jointly develop digital solutions for insurance companies in Japan and aim for commercialization in fiscal 2023. Moving forward, the two companies will continue to pursue various initiatives to contribute to further innovations in the healthcare sector. Fujitsu will work with insurance companies, medical institutions, pharmaceutical companies and medical device manufacturers to build a digital health ecosystem in which a wide range of data can be effectively linked and used with the latest digital technology in order to realize personalized healthcare throughout the entire life cycle. This initiative represents part of Fujitsu's ongoing efforts to contribute to the creation of a healthy society as part of its vision for "Healthy Living" under its global business brand Fujitsu Uvance to create a sustainable world.Salesforce aims to realize "Connected Healthcare," which provides innovative and optimal healthcare to patients on an ongoing basis by connecting various healthcare stakeholders with patients through its ?Health Cloud."Yoshinami Takahashi, (Corporate Executive Officer, EVP) Fujitsu Limited, comments:"We are excited to start collaboration with Salesforce Japan in the healthcare field. By leveraging our respective strengths, I am confident that we can develop and provide innovative solutions to a wide range of challenges and tasks in this field. The vision of "Healthy Living," one of the key focus areas under our global business brand Fujitsu Uvance is to create a world that enriches the life experience of everyone and continues to expand their potential. In order to realize this vision, it is essential to solve cross-cutting issues among consumers, insurance companies, medical institutions, pharmaceutical companies and other players. Fujitsu will create a digital health ecosystem to effectively link the data held by these players at the initiative of individuals to create new value and ultimately solve various issues. Through this collaboration, we ultimately aim to deliver new solutions under our portfolio of "Healthy Living" offerings, contributing not only to the transformation of healthcare in Japan, but throughout the whole world."Hidenori Tamura (Managing Executive Officer), Salesforce Japan Co., Ltd., Enterprise Finance & Region DX Sales Headquarters comments:"There is a gap between the healthcare services demanded by consumers and the services actually provided. A Salesforce research shows that more than 80% of consumers are interested in personalized health services, while only about 30% of companies actually provide them. To meet the needs of consumers, it is essential for various players in the industry to connect and collaborate with patients to create solutions. We have positioned our ?Health Cloud? as a solution where patients and healthcare players can connect and where healthcare players can create new solutions and values together. Through our solutions centering on the ?Health Cloud,? we will promote patient-centered DX in Japan. As a major step towards achieving this goal, we will work with Fujitsu to provide innovative healthcare services and experiences that are optimal for each patient."Amit Khanna SVP & GM, Health Care and LifeSciences, Salesforce, Inc. comments:"Care is not just about one moment in time - care is longitudinal. In order to transition to more preventative, holistic care, the healthcare industry needs to embrace more connected, collaborative solutions and start integrating data from across different healthcare platforms to get a full picture of the patient. With this integrated end-to-end view, the healthcare industry can start working towards delivering personalized, tailored care to every patient."(1) Patient journey :The process of a patient's behavior and feelings during the period of treatment, such as seeking medical attention or taking medication, after the patient has developed a disease.About FujitsuFujitsu?s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About SalesforceSalesforce is a global leader in customer relationship management (CRM), helping companies of all sizes and verticals digitally transform and reach their customers at 360 degrees. Learn more about Salesforce (NYSE: CRM) at www.salesforce.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry ACN Newswire

EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry

21 6 月, 2022
HONG KONG, Jun 21, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the signing of its first sustainability-linked facility ("SLL Facility") totalling HK$ 700 million with The Hongkong and Shanghai Banking Corporation Limited ("HSBC") as sole lender and sustainability structuring bank. The inaugural dual-tranche SLL Facility is a first-of-its-kind for a healthcare services provider in Hong Kong, complementing the Group's established status as a leading industry pioneer and reaffirms the importance of sustainability in the Group's future growth strategy. The SLL Facility is comprised of a revolving credit and a term loan, and the proceeds will be used for working capital.The Group is committed to the United Nations 2030 Sustainable Development Goals and has developed a number of clear targets against each of the environmental, social, and governance ("ESG") elements. These include reducing energy consumption, increasing employee engagement, and achieving a globally recognized standard in relation to corporate governance.SGS Hong Kong Limited, a leading sustainability consultancy firm, acted as ESG consultant on the SLL Facility.Ms. Ada Wong, Executive Director, Chief Strategy Officer & Chief Investment Officer of EC Healthcare said, "This maiden sustainability-linked facility is an important milestone and represents another bold step in the Group's sustainability journey. As the leading healthcare and medical services provider in Hong Kong, this transaction reflects the Group's desire to integrate sustainable development into its core business strategy as well as implement best practices into the daily operations of its various brands. We are delighted to align the Group's financing strategy with a number of impactful ESG goals, reinforcing our commitment to sustainability in the long-term. We are excited to set the stage for subsequent sustainable finance transactions in the Hong Kong healthcare market."About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Charmaine Ip Tel: (852) 2136 6952 / 2169 0467 / 3920 7649 Fax: (852) 3170 6606 Email: ech@iprogilvy.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
DX Leaders Strategy Forum Goes Hybrid in PH ACN Newswire

DX Leaders Strategy Forum Goes Hybrid in PH

21 6 月, 2022
MANILA, Jun 21, 2022 - (ACN Newswire via SEAPRWire.com) - EDX Pte. Ltd. will host DX Leaders Strategy Forum Philippines 2022, taking place at Diamond Hotel Philippines on August 24 and online on August 25, featuring 40+ international and local speakers and facilitators.EDX Pte. Ltd. is proud to bring its DX Leaders Strategy Forum to the Philippines for the first time. DX Leaders Strategy Forum Philippines 2022 will open opportunities for collaborative discussions and effective learning and application of digital and operational strategies to uplift the digital landscape of the country. Initial list of speakers will be Francisco Castillo of Maynilad Water Services, Inc., LCol. Francel Margareth Padilla-Taborlupa of Philippine Army, Chito Jacinto of ISACA Manila, Marlon Sorongon of Maybank Philippines | Maybank NY, Dennis Crimen of Philippines Airasia, Paul John Pena of the Senate of the Philippines, and Lito Villanueva of RCBC.EDXchange sessions on relevant subjects such as modern data technologies, hybrid IT, cloud migration, future-proofing IT infrastructures, cybersecurity in a hybrid environment, zero-trust security, and AI-driven automation in a hybrid workplace can be expected.The two-day hybrid event is solely open to business decision makers and influencers who have been invited. EDX Pte. Ltd. is seeking CxOs, SVPs and VPs of Technology and Digital Transformation, as well as Heads of IT Operations from the top 100 firms in the Philippines. Invitations can be requested at https://philippines2022.edxevents.com/request-invitation/. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
BayWa r.e. Expands and Strengthens Renewable Energy Business with Wind Projects Representative Office Opening in Lang Son Province in Vietnam ACN Newswire

BayWa r.e. Expands and Strengthens Renewable Energy Business with Wind Projects Representative Office Opening in Lang Son Province in Vietnam

21 6 月, 2022
HO CHI MINH CITY, VIETNAM, Jun 21, 2022 - (ACN Newswire via SEAPRWire.com) - Global renewable energy developer, service provider and distributor, BayWa r.e., today announced the opening of its Wind Projects Representative office in Lang Son Province, Vietnam. The opening of the Wind Projects Representative office will strengthen BayWa r.e.'s position as a key renewable energy developer in Vietnam and enable the company to provide a wider range of wind energy services in the country.Mr. Brian Barry (Head of Wind Asia, BayWa r.e.), Mr. Nguyen Dinh Dai (Director of DOIT), Mr. Daniel Gaefke (APAC Director, BayWa r.e.), Mr. Daniel Emunds (German Embassy representative, Economic Affairs and Development Cooperation)Loi Dang Van (Wind Project Developer, BayWa r.e.), Mr. Brian Barry (Head of Wind Asia, BayWa r.e.), Mr. Daniel Gaefke (APAC Director, BayWa r.e.), Stephanie Tan (Project Manager, Wind Project Development, BayWa r.e.), Nam Le (Senior Wind Project Developer, BayWa r.e.)The opening ceremony of the office was officiated by local government officials, which included leaders of the province's People Committee, relevant departments of Industry and Commerce, Planning and Investment, Natural Resources & Environment, Agriculture and Rural Development, Transportations and local districts and German Embassy representative Mr. Daniel Emunds, Economic Affairs and Development Cooperation as well as local partners and contractors. The new representative office is expected to promote positive socio-economic developments and impact for the local community.Mr. Brian Barry, Head of Wind Asia, BayWa r.e. said "We are excited to see the exponential growth of BayWa r.e. in Vietnam and look forward to working closely with provincial and country stakeholders. We hope that through our investments into Vietnam and especially the Lang Son province at present, we will be able to bring more value to our stakeholders and communities living in the area. This is a step closer for us to work towards achieving Vietnam's strategy for sustainable and clean energy development and to facilitate the country's ambition of becoming net-zero by 2050."Mr. Pham Hung Truong, Chief of Office of the People's Committee of Lang Son shared: "We welcome BayWa r.e. opening its Representative Office in Lang Son. It is hoped that the Representative Office will be an effective bridge between the company and local government agencies, promoting the successful implementation of investment and construction of wind power projects of BayWa r.e. in Lang Son, contributing to the socio-economic development of the province. We acknowledge the valuable support of BayWa r.e. to the two primary schools of Khuoi Lay and Suoi Long recently; at the same time, we believe that in the coming time, your company will continue accompanying the local government to strengthen forms of support to local communities in the spirit of "Harmonious benefits, sharing risks!".BayWa r.e. first established its presence in Vietnam in 2020, with its head office located at Ho Chi Minh City. BayWa r.e. launched new services to its 'on-the-ground' operation in Vietnam, opening a solar distribution warehouse and new office facilities in Ho Chi Minh City to bring direct local access to solar PV, inverters, and much more renewable energy solutions. Since then, the company has been an active renewable energy partner in the Corporate & Industrial segment in Vietnam, developing Solar and Wind Projects, and providing Solar Distribution services.In addition, BayWa r.e.'s development team also has a 400MW pipeline of wind energy projects across sites in north Vietnam and is developing 150MW solar projects in the south of the country. In Lang Son province, BayWa r.e. is planning to develop 240MW of wind energy projects to leverage Vietnam's wind capacity.Added Mr. Barry, "Our office opening is a key milestone and the culmination of 2 years of development and investment in Lang Son. But this is just the beginning of our commitment and partnership with Lang Son as we prepare for the implementation of our wind projects. With our Lang Son office now established we will grow our Lang Son team to scale up our activities in preparation for our investment decision and the construction of the provinces first wind projects.""Having an office located where we are operational will enable more efficient work processes and allow direct access for stakeholders to communicate with BayWa r.e. This will also facilitate future development of wind projects in this province. Our on-site employees will also be able to effectively monitor current and future wind energy projects, which will ensure the longevity of the developments."BayWa r.e. recently announced the successful completion and handover of new sanitary facilities for Khuoi Lay Elementary School and Suoi Long Elementary School in Lang Son Province. This is part of BayWa r.e.'s long standing commitment to helping local communities, and also reaffirms the company's continued dedication to drive sustainable growth for the people of Lang Son province.BayWa r.e. AG (BayWa r.e.)At BayWa r.e. we r.e.think energy - how it is produced, stored and can be best used to enable the global renewable energy transition that is essential to the future of our planet.We are a leading global developer, service supplier, distributor and solutions provider and have brought over 4.5GW of energy online and manage over 10GW of assets. We are also an Independent Power Producer with an expanding energy trading business.BayWa r.e. works with businesses worldwide to provide tailored renewable solutions. Operating 100% carbon neutral, we are also committed to our own sustainability journey.Every day, we are working hard to actively shape the future of energy in a diverse, equitable and inclusive workplace.Our shareholders are BayWa AG, a EUR19.8 billion global business, and Energy Infrastructure Partners, a leader in energy infrastructure investment. Visit https://www.baywa-re.com/en/.Contact information:PRecious Communications for BayWa r.e. AGFoo En JingTel: +65 6303 0567E-mail: baywa-re@preciouscomms.com BayWa r.e. AGSalim PathanMarketing Manager, APACTel: +66 62 698 7162Email: salim.pathan@baywa-re.comMark CooperCorporate CommunicationsTel: +49 89 383932 3611E-mail: mark.cooper@baywa-re.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
ESI Singapore agenda and speakers revealed including PSG, Crypto.com Capital, ONE Esports and Mineski Global ACN Newswire

ESI Singapore agenda and speakers revealed including PSG, Crypto.com Capital, ONE Esports and Mineski Global

21 6 月, 2022
Singapore, June 21, 2022 - (ACN Newswire via SEAPRWire.com) - B2B esports events and media company Esports Insider is excited to reveal the agenda and full lineup of speakers for our international two-day esports business conference - ESI Singapore.The event, which is co-hosted with Singapore-based Esports marketing agency, REDD+E, takes place on 6-7th July. As ESI’S first in-person event in the APAC region, the conference will provide delegates with two days of world leading sessions from industry leaders both within the region and from around the world, and valuable face to face networking opportunities.Speakers from the likes of AFC Ajax, MOONTON, PSG, Crypto.com Capital, Mineski, GRID, Galaxy Racer, EVOS, Bayes, Ampverse and more will grace #ESISG with their presence and ensure the stage is chokablok with knowledge and insight across the two days. “With more and more activities ramping up and more professional esports events taking place, the industry sentiment is certainly looking positive for Asia’s esport”, said Yip Ren Kai, Managing Director & Co-founder of Redd+E . “As the co-host of this industry showcase, we’re really excited to be able to see top industry leaders coming together to share on the outlook of esports in Asia, and bring world-class actions to the growing vibrant esports community.” Held at Singapore’s historic CHIJMES Hall, ESI Singapore will include a unique programme of content with over 40 biggest names in esports including C-Levels and executives who will be joining the panels to discuss a number of topics, on everything from commercialisation and partnerships, to esports’ unique place in the South East Asian ecosystem, crossover industries including blockchain and Web3; and many more. The agenda, which can be viewed in full here, includes:Day 1 - 6th JulyProfessional Esports Games In The Global Arena – A Successful Blueprint For The Future Of Events In AsiaSpeakersMr Hung Do Viet - General Secretary - VIRESA (Vietnam National Esports Federation)Mr Yip Renkai - MD and Co-founder - Redd+EThe Rise Of Mobile Esports In AsiaSpeakersDylan Chia - Head of MPL Indonesia - MOONTON GamesCarlos Alimurung - CEO - ONE EsportsStefan Chong - Business Development Manager - EVOS EsportsMoritz Maurer - CEO - GRIDNick Vanzetti- MD - ESL Asia Pacific JapanDigital Brand Exposure Meets Ai - The Importance Of Data Analytics For Brand PartnershipsSpeakersArwin Fallah Shirazi - CEO - ShikensoMasashi Yamazaki - COO & Head of Business Development - GamingDEngaging With The SEA AudienceSpeakersFrank Sliwka - COO - EpulzeAllan Phang - CMO - Galaxy RacerEsports & Sponsorship In Times Of Pre And Post CovidSpeakersKalvin Chung - CEO - MnM GamingRingo Lung - Head of Partnerships - Talon EsportsFootball Clubs In Esports: From Messi To MirageSpeakersTim Slot - Esports Lead - AFC AjaxYassine Jaada - Chief Gaming Officer - PSG EsportsMark Chew - Managing Director & Co-Founder - Redd+EDay 2 - 7th JulyEsports Teams And Revenue Streams - The Importance Of DiversificationFrom Web2 To Web3 - How Blockchain Games Changes The Landscape Of EsportsSpeakersCholo Maputol - CEO - Play It Forward DAOCharlie Baillie - Chief Strategy Officer - AmpverseMartin Dachselt - CEO - BayesNathan N - Co-Founder - Ancient8Investing In Web3, Gaming And Esports In 2022SpeakersHong Qi Yu - CEO - Tokenize ExchangeBen Wee - Vice President - Crypto.com CapitalThe event is supported by Silver Sponsors Bayes Esports and Ampverse, Stage Sponsors GRID; sponsors Shikenso, SPORTFIVE and media and strategic partners ACN Newswire, Swipe Right PR and 80LV.Alongside ESI Singapore, Esports Insider’s pitch investment competition The Clutch will also make its return in a physical format on 7th July, with applications still open, and closing on June 28th.Sam Cooke, Managing Director and Co-Founder at Esports Insider, added: “We are delighted to bring back the physical format of The Clutch in 2022. This year we will host its fifth edition and showcase the most ground-breaking startups and first-rate pitches from small businesses based in and around Southeast Asia.“Since its inception in 2019 at ESI London, we have continued to see more and more startups enter the esports space and here at Esports Insider, we are proud to continue providing a platform for those companies looking to stand out, and push boundaries.”Singapore is ESI’s second Major conference in 2022, with the schedule including three Major global events; the 2022 events brochure is viewable here.Next on the agenda, ESI will head back to London, for its biggest yet event taking place at BOXPARK Wembley over 5-7th September. Early Bird tickets are now available to purchase until 15th July. ESI Singapore - Press Kit- Logos | Graphics | WebsiteAbout Esports InsiderBased in London and founded in 2016, Esports Insider is an industry-focused esports news platform, B2B agency, media and events company.ESI runs a world-leading and international esports industry news site, operates The Esports Journal magazine and has run more industry events than any other company globally, from London to Los Angeles. Other arms of the company include ESI Media, as well as ESI Connect, its agency arm which offers services across Brokerage, Consultancy and Campaign Activation.General Enquiries:-info@esportsinsider.comPRs & pitches:- news@esportsinsider.comWebsite // Twitter // Facebook // Linkedin // Instagram // YouTube // DiscordAbout Redd+ERedd+E, through its parent company Reddentes Sports is a marketing agency that delivers smart and impactful solutions in the areas of sport and esports. Our services include media rights consulting, commercialisation development, event consulting, project management, organisational consultancy for sports associations, athlete management and marketing consultancy. Our goal is to provide services and value to transform organisations, businesses and communities by achieving their objectives through esports.Facebook // Linkedin // Instagram Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
SEAPRWire Announces Major Expansion of Southeast Asia Press Release Media Network SeaPRwire

SEAPRWire Announces Major Expansion of Southeast Asia Press Release Media Network

21 6 月, 2022
Singapore – As part of a major expansion of its guaranteed press release media placements network, Southeast Asia press release distribution service provider SEAPRWire announced the further expansion of their media network in Singapore, Vietnam, Philippines, Thailand and Hong Kong. Through a series of strategic partnerships and media alliances, SEAPRWire now offers clients more than 60 Southeast Asia guaranteed website placements with every press release distribution, a number that now makes its guaranteed placements network one of the largest in the Southeast Asia region Marketplace in terms of the number of media outlets. The expanded media network of SEAPRWire includes: 6 media outlets in Greater China, including: AsiaEase.com, EastMud.com, NetDace.com, AsiaFeatured.com, AseanFun.com and AseanTrend.com3 media in Singapore, including SingaporeEra.com, VOASG.com, TodayInSG.com3 media in Hong Kong, including HKBrowse.com, TIHongKong.com, DirHongKong.com3 Philippine media, including PHNotes.com, EventPH.com, PHNewLook.com3 Vietnamese media, including VNFeatured.com, PostVN.com, VietnamClipping.com3 Thai media, including AccessTH.com, InsightTH.com, ThaiLandLatest.com “For PR professionals, marketers, small businesses and organizations trying to reach Souteast Asia media and influencers for coverage of their announcements, traditional wire services haven’t offered them strong local reach, cost-effectiveness or a nuanced understanding of the market,” said Yaqin Tang, Newswire CMO. “SEAPRWire’s laser-focused dedication to the Souteast Asia market, our new guaranteed placement partnerships and our embrace of affordable multimedia make it a powerful, incomparable value platform for greater visibility.” In May, SEAPRWire launched an strategy partnership with the leading newswire service provide EQS. The partnership includes media list expansion and media outreaching business cooperation. The partnership covers mainland China, Hong Kong, Singapore, Thailand, Vietnam, Malaysia, Indonesia, and the Philippines. Both parties look forward to further cooperation in the future. “This is a strategic alliance that will strengthen the quality and distribution of content to multi-lingual media in the Asia,” Yaqin said. About SEAPRWire SEAPRWire (https://www.seaprwire.com/) is a market-moving financial and business news source in Southeast Asia, trusted by institutional investors and fintech platforms in Asia to identify trading and investing opportunities and build investor experiences. It has a strong media network in Southeast Asia, indexing news from thousands of worldwide sources. SEAPRWire’s media network support multi-lingual press release distribution, including English, Chinese, Vietnamese, Thai, Malay, Indonesian, Filipino and more. For more information, please email cs@seaprwire.com or https://newsroom.seaprwire.com/. Media contact Brand: SEAPRWire Contact: Tina, Marketing Manager Email: cs@seaprwire.com Website: https://seaprwire.com SOURCE: SEAPRWire
More
SEAPRWire宣布在东南亚地区的新闻稿媒体网络重大拓展 SeaPRwire

SEAPRWire宣布在东南亚地区的新闻稿媒体网络重大拓展

21 6 月, 2022
Singapore - 作为其新闻稿媒体投放网络重大扩展的一部分，新闻稿分发服务提供商 SEAPRWire 宣布进一步扩展其在新加坡、越南、菲律宾、泰国和香港的媒体网络。 通过一系列战略合作伙伴关系和媒体联盟，SEAPRWire 现在为客户的每一篇新闻稿提供 60 多个东南亚地区媒体展示。这个数字已经使SEAPRWire成为东南亚地区最大的媒体网络分发服务机构之一。 拓展后的SEAPRWire媒体网络达到60多家媒体；服务区域覆盖东盟10国及香港；支持的语言包括：英语、繁体中文、简体中文、马来语、印度尼西亚语、越南语、泰语、菲律宾语等。新增的媒体包括: 大中华地区6家媒体（简体中文、繁体中文、英文）：com, EastMud.com, NetDace.com, AsiaFeatured.com, AseanFun.com, AseanTrend.com 新加坡3家媒体（简体中文、英文）：com, VOASG.com, TodayInSG.com 香港3家媒体（繁体中文，英文）：com, TIHongKong.com, DirHongKong.com 菲律宾3家媒体（菲律宾语、英文）：com, EventPH.com, PHNewLook.com 越南3家媒体（越南语、英文）：com, PostVN.com, VietnamClipping.com 泰国3家媒体（泰文、英文）：com, InsightTH.com, ThaiLandLatest.com “对于公关专业人士、营销人员、小企业和组织，他们试图通过东南亚媒体和KOL以报道他们的新闻事件。而传统的媒体服务并没有为他们提供强大的本地影响力、成本效益或对市场的细致入微的了解，”SEAPRWire首席营销官YQ Tang表示，“SEAPRWire 专注于东南亚市场，我们增加了新的合作伙伴，并且积极拥抱社交网络多媒体，使SEAPRWire成为一个强大的价值平台，以提高知名度。” 2022年5 月，SEAPRWire 和 EQS Group (www.eqs.com) 宣布在亚洲（东亚和东南亚）建立媒体合作伙伴关系。合作内容包括媒体名单扩展和媒体外展业务合作。合作范围涵盖中国大陆、香港、新加坡、泰国、越南、马来西亚、印度尼西亚和菲律宾。双方期待未来进一步合作。 “这是一个战略联盟，将加强亚洲多语种媒体内容的质量和分发，”YQ Tang说。 关于SEAPRWire SEAPRWire (https://www.seaprwire.com/)是东南亚具有影响力的金融和商业新闻社，深受亚洲机构投资者和金融科技平台的信赖。该平台可识别交易和投资机会并建立良好的投资者体验。它在东南亚地区具有强大的媒体网络，索引来自全球数千个来源的新闻。SEAPRWire 的媒体网络支持多语种新闻稿发布，包括英语、繁体中文、简体中文、越南语、泰语、马来语、印度尼西亚语、菲律宾语等。 For media inquiry: Tina Lee, SEAPRWire cs@seaprwire.com https://seaprwire.com
More
Ev Dynamics is Commissioned to Build Hong Kong’s First Accessible Electric Bus ACN Newswire

Ev Dynamics is Commissioned to Build Hong Kong’s First Accessible Electric Bus

20 6 月, 2022
HONG KONG, Jun 20, 2022 - (ACN Newswire via SEAPRWire.com) - Ev Dynamics (Holdings) Limited (the "Company", Stock Code: 476, together with its subsidiaries, collectively "Ev Dynamics" or the "Group"), a provider of new energy vehicles and integrated technology solutions, has received another purchase order from the Hong Kong Productivity Council to deliver a pure electric bus for use by a Hong Kong non-governmental organisation ("NGO"), which follows the Council's earlier order of electric buses for the Airport Authority Hong Kong and the Hong Kong Anti-Cancer Society.Ev Dynamics' pure electric bus is powered by sustainable high energy density batteries and is designed to adapt to and manoeuvre through complicated city road systems.The bus is equipped with an extra-low platform for easy accessibility for seniors and those with impaired mobility. It has enough space to house up to 33 regular seats and two wheelchairs.Developed by the Group under a new purchase agreement with the Hong Kong Productivity Council, the electric bus boasts a light aluminium alloy body structure with a highly efficient traction motor system, complemented by a full load-bearing electric bus chassis, high energy density batteries that ensure extended stable power output, and other innovative technological features. Moreover, the vehicle is set to be the first socially inclusive electric bus in Hong Kong, having been specifically designed to be accessible to seniors and those with disabilities, with features such as an extra-low platform for easy accessibility and enough space to house up to 33 regular seats and two wheelchairs. It also boasts the unique advantages of a relatively low weight and low energy consumption, making it a cost-efficient and sustainable transport solution. Subject to type approval, inspection and registration granted by the Transport Department, the Group expects delivery to be completed together with an EV charger installation project located next to the NGO's service centre in Tai Po by the end of next year, and will continue to provide quality after-sales maintenance and repair services to the end-user NGO.Miguel Valldecabres Polop, CEO of Ev Dynamics said, "We are always proud and excited when our products are brought to the public. In the past year, we have been expanding our global reach in the international electric vehicle market, especially in high-growth areas such as Europe, Latin America and Asia, but we are especially honoured to have received an order from our home market of Hong Kong. The pure electric bus showcases the Group's most innovative technological and product advantages, boasting zero emissions, reliable operation and sustainable design systems that will help to realise green targets related to the reduction of roadside air and noise pollution. The bus is also designed to be accessible to all members of society, including seniors and those with impaired mobility who may face obstacles when riding public transportation on a regular basis. We expect it to set the standard for energy efficient public transport, as the future of transport lies in electromobility, as well as further Ev Dynamics' market expansion in the local market." About Ev Dynamics (Holdings) Limited (Stock Code: 476)Ev Dynamics (Holdings) Limited is a pioneer and prominent player in China's new energy commercial vehicles market, as well as a whole-vehicle manufacturer of specialty passenger vehicles and new energy passenger vehicles. It is an integrated driving and logistics solutions provider with a solid technological foundation in diverse areas including new energy platform power systems and their key components. The Group has a production base in Chongqing, boasts extensive domestic and overseas sales networks, and focuses on serving high-growth markets in Southeast Asia, Europe and Latin America.Media EnquiriesStrategic Financial Relations LimitedVicky Lee +852 2864 4834 vicky.lee@sprg.com.hk Phoebe Leung +852 2114 4172 phoebe.leung@sprg.com.hkBrigid Lee +852 2114 4313 brigid.lee@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

The 5th Brasil Investment Forum Brought Together Global Business Leaders, Actively Promotes the High-quality Investment Opportunities in Brazil

20 6 月, 2022
SHANGHAI, Jun 20, 2022 - (ACN Newswire via SEAPRWire.com) - The 5th Brasil Investment Forum ("BIF 2022"), the largest foreign investment forum in Latin America jointly organized by Brazilian Trade and Investment Promotion Agency ("ApexBrasil"), Inter-American Development Bank and the Federal Government of Brazil, concluded successfully on 15 June 2022. During the forum, heavyweight speakers shared views on a range of topics, discussed the business environment and opportunities in Brazil, and promoted numbers of high-quality investments.BIF 2022 has achieved huge success with various record-breaking figures this year. The forum has attracted and presented 157 investment projects with an estimated investment value of USD66.4 billion, expecting to create 200,000 direct and indirect job opportunities in Brasil. The investment projects are mainly in transportation and infrastructure sectors, namely airports, railways, highways, ports, oil and gas, and energy. Among which, investors showed the strongest interest in railway market, 61 railway projects with a total investment value of US$31.81 billion were presented during the forum. The second most popular sector was road market. The contract value of the road projects reached USD 22.2 billion with the construction of 14,383 kilometers of roads. Moreover, 63 projects in airport sector worth UDS9.1 billion, 2 transmission auction projects in energy sector worth USD3.2 billion and 2 exploration projects in oil and gas sector worth USD246 million were presented during BIF 2022.Due to the Covid-19 pandemic, BIF 2022 adopted the online-offline hybrid format for the first time, however, the number of attendees this year exceeded 5,000, beating its historical records. 800 entrepreneurs and executives from 61 countries participated the forum at the World Trade Center of Sao Paulo, and over 4,000 potential investors from 100 countries participated online, totaling more than 5,000 attendees. The forum brought together over 350 representatives of the Brazilian federal and state governments as well as the CEOs of leading multinationals for 19 keynote speeches and discussions over the two consecutive days, covering a variety of hot topics including the latest business environment in Brazil, innovative business models, equity investment initiatives, and movements in global value chains. According to Augusto Pestana, president of ApexBrasil, the business environment in Brazil has been improving in an unprecedented magnitude, providing conditions for the entrepreneur to multiply his business, transforming the expansion into more goods and services, new products, and more jobs and income for millions of Brazilians. "Brazil is a country that modernizes itself and opens itself to the world with pragmatism and courage, a country that seeks the best standards and practices, as is well demonstrated by the beginning of our OECD entry process," said Pestana. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
科轩动力获委托建造香港首辆无障碍电动巴士 ACN Newswire

科轩动力获委托建造香港首辆无障碍电动巴士

20 6 月, 2022
HONG KONG, Jun 20, 2022 - (亚太商讯 via SEAPRWire.com) - 新能源汽车及技术综合解决方案供应商科轩动力（控股）有限公司（「公司」；股份代号：476，连同其附属公司，统称「科轩动力」或「集团」）再次接获香港生产力促进局采购订单，交付一辆纯电动巴士供一个香港非政府机构（「非政府机构」）使用。香港生产力促进局较早前已为香港机场管理局及香港防癌会向集团采购电动巴士。科轩动力的纯电动巴士采用可持续的高能量密度电池，能灵活穿梭于复杂的城市道路系统。超低地台设计方便长者和残疾人士上落，并提供足够空间容纳多达33个标准座位和两台轮椅。该辆电动巴士根据集团与香港生产力促进局的新采购协议而开发，采用轻身的铝合金车身结构和高效的牵引动力系统，配以全承重式电动巴士专用底盘、高能量密度电池确保功率输出长期稳定、以及其他创新科技特点。此外，该车辆将成为香港首款社会共融电动巴士，其超低地台等特别设计方便长者和残疾人士上落，并提供足够空间容纳多达33个标准座位和两台轮椅。该车辆的其他独有优势还包括较轻巧和低能耗，让其成为具成本效益和可持续的运输解决方案。待运输署发出类型审核、检验及登记后，集团预计将于明年年底前连同位于大埔非政府机构服务中心旁的电动车充电站安装项目完成交付。集团将继续为该终端用户非政府机构提供优质的售后保养和维修服务。科轩动力行政总裁Miguel Valldecabres Polop表示：「我们对产品面世深感自豪，也非常雀跃。在过去一年，我们一直在扩大国际电动汽车市场的覆盖，尤其是欧洲、拉丁美洲和亚洲等高增长地区，但我们对收到香港本地市场订单感到特别荣幸。该纯电动巴士展示了集团最新技术和产品优势，其零排放、运作可靠和可持续设计系统有助实现与减少路边空气和噪音污染相关的绿色目标。该巴士的设计方便社会各界人士使用，包括乘坐公共交通工具时有困难的长者及行动不便人士。电动汽车就是交通的未来，我们预计该车辆将会成为节能公共交通的标准，并帮助科轩动力在香港本地市场进一步扩张。」关于科轩动力（控股）有限公司（股份代号：476）科轩动力（控股）有限公司为新能源商用车的先行者和实践者、专用客车和新能源客车整车生产商，在新能源平台化电系统及关键零部件方面有着坚实的技术基础，是出行与物流综合解决方案的供应商。集团在重庆设有生产基地，拥有广泛的海内外销售网路，及重点开拓东南亚、欧洲和拉丁美洲的高增长市场。新闻垂询 纵横财经公关顾问有限公司 李惠儿 +852 2864 4834 vicky.lee@sprg.com.hk 梁家仪 +852 2114 4172 phoebe.leung@sprg.com.hk 李溢晴 +852 2114 4313 brigid.lee@sprg.com.hk 网址：www.sprg.com.hk Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)
More